Innovative SonoCloud-9 Device for Blood Brain Barrier Opening in First Line Temozolomide Glioblastoma Patients.

NCT04614493 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Initial Radiological Diagnosis Eligible for Tumor Resection
Initial Radiological Diagnosis Compatible With Newly Diagnosed Glioblastoma (IDH Wild-type)
Eligible for the Standard of Care Including Concurrent Temoradiation and Adjuvant Temozolomide

Interventions

DEVICE: SonoCloud-9 (SC9) device
DRUG: Temozolomide according Stupp protocol

Sponsor

Assistance Publique - Hôpitaux de Paris